An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease

References

• Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity. 2002;16:479–92. doi:10.1016/S1074-7613(02)00283-2. PMID:11911831.
   PubMed Web of Science ®Google Scholar
• Bamias G, Martin C 3rd, Marini M, Hoang S, Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ, et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol. 2003;171:4868–74. doi:10.4049/jimmunol.171.9.4868. PMID:14568967.
   PubMed Web of Science ®Google Scholar
• Bamias G, Mishina M, Nyce M, Ross WG, Kollias G, Rivera-Nieves J, Pizarro TT, Cominelli F. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc Natl Acad Sci U S A. 2006;103:8441–6. doi:10.1073/pnas.0510903103. PMID:16698931.
   PubMed Web of Science ®Google Scholar
• Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, McMichael AJ, Bell JI. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci U S A. 1997;94:4615–9. doi:10.1073/pnas.94.9.4615. PMID:9114039.
   PubMed Web of Science ®Google Scholar
• Bittner S, Knoll G, Füllsack S, Kurz M, Wajant H, Ehrenschwender M. Soluble TL1A is sufficient for activation of death receptor 3. FEBS J. 2016;283:323–36. doi:10.1111/febs.13576. PMID:26509650.
   PubMed Web of Science ®Google Scholar
• Bittner S. & Ehrenschwender, M. Multifaceted death receptor 3 signaling-promoting survival and triggering death. FEBS Lett. 2017;591:2543–55. doi:10.1002/1873-3468.12747. PMID:28686297.
   PubMed Web of Science ®Google Scholar
• Wen L, Zhuang L, Luo X, Wei P. TL1A-induced NF-κB Activation and c-IAP2 Production Prevent DR3-mediated Apoptosis in TF-1 Cells. J Biol Chem. 2003;278:39251–8. doi:10.1074/jbc.M305833200. PMID:12882979.
   PubMed Web of Science ®Google Scholar
• Papadakis KA, Prehn JL, Landers C, Han Q, Luo X, Cha SC, Wei P, Targan SR. TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. J Immunol. 2004;172:7002–7. doi:10.4049/jimmunol.172.11.7002. PMID:15153521.
   PubMed Web of Science ®Google Scholar
• Pappu BP, Borodovsky A, Zheng TS, Yang X, Wu P, Dong X, Weng S, Browning B, Scott ML, Ma L, et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J exp med. 2008;205:1049–62. doi:10.1084/jem.20071364. PMID:18411337.
   PubMed Web of Science ®Google Scholar
• Takedatsu H, Michelsen KS, Wei B, Landers CJ, Thomas LS, Dhall D, Braun J, Targan SR. TL1A. TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology. 2008;135:552–67. doi:10.1053/j.gastro.2008.04.037. PMID:18598698.
   PubMed Web of Science ®Google Scholar
• Meylan F, Song YJ, Fuss I, Villarreal S, Kahle E, Malm IJ, Acharya K, Ramos HL, Lo L, Mentink-Kane MM, et al. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Mucosal Immunol. 2011;4:172–85. doi:10.1038/mi.2010.67. PMID:20980995.
   PubMed Web of Science ®Google Scholar
• Shih, DQ, Zheng L, Zhang X, Zhang H, Kanazawa Y, Ichikawa R, Wallace KL, Chen J, Pothoulakis C, Koon HW. Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis. Mucosal Immunol. 2014;7:1492–503. doi:10.1038/mi.2014.37. PMID:24850426.
   PubMed Web of Science ®Google Scholar
• Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–24. doi:10.1038/nature11582. PMID:23128233.
   PubMed Web of Science ®Google Scholar
• Fang L., Adkins B, Deyev V, Podack ER. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J Exp Med. 2008;205:1037–48. doi:10.1084/jem.20072528. PMID:18411341.
   PubMed Web of Science ®Google Scholar
• Richard AC, Tan C, Hawley ET, Gomez-Rodriguez J, Goswami R, Yang XP, Cruz AC, Penumetcha P, Hayes ET, Pelletier M, et al. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. J Immunol. 2015;194:3567–82. doi:10.4049/jimmunol.1401220. PMID:25786692.
   PubMedGoogle Scholar
• Meylan F, Hawley ET, Barron L, Barlow JL, Penumetcha P, Pelletier M, Sciumè G, Richard AC, Hayes ET, Gomez-Rodriguez J, et al. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunol. 2014;7:958–68. doi:10.1038/mi.2013.114. PMID:24368564.
   PubMed Web of Science ®Google Scholar
• Yu X, Pappu R, Ramirez-Carrozzi V, Ota N, Caplazi P, Zhang J, Yan D, Xu M, Lee WP, Grogan JL. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol. 2014;7:730–40. doi:10.1038/mi.2013.92. PMID:24220298.
   PubMed Web of Science ®Google Scholar
• Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464:1367–70. doi:10.1038/nature08900. PMID:20200518.
   PubMed Web of Science ®Google Scholar
• Jia Y, Fang X, Zhu X, Bai C, Zhu L, Jin M, Wang X, Hu M, Tang R, Chen Z. IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response. Am J Respir Cell Mol Biol. 2016;55:675–83. doi:10.1165/rcmb.2016-0099OC. PMID:27314535.
   PubMed Web of Science ®Google Scholar
• Meylan F, Davidson TS, Kahle E, Kinder M, Acharya K, Jankovic D, Bundoc V, Hodges M, Shevach EM, Keane-Myers A, et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity. 2008;29:79–89. doi:10.1016/j.immuni.2008.04.021. PMID:18571443.
   PubMed Web of Science ®Google Scholar
• Wroblewski VJ, Witcher DR, Becker GW, Davis KA, Dou S, Micanovic R, Newton CM, Noblitt TW, Richardson JM, et al. Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. Biochem Pharmacol. 2003;65:657–67. doi:10.1016/S0006-2952(02)01612-X. PMID:12566095.
   PubMed Web of Science ®Google Scholar
• Possa SS, Leick EA, Prado, CM, Martins, MA, Tiberio IF. Eosinophilic inflammation in allergic asthma. Front Pharmacol. 2013;4:46. doi:10.3389/fphar.2013.00046. PMID:23616768.
   PubMed Web of Science ®Google Scholar
• Zhan C, Patskovsky Y, Yan Q, Li Z, Ramagopal U, Cheng H, Brenowitz M, Hui X, Nathenson SG, Almo SC. Decoy strategies: the structure of TL1A:DcR3 complex. Structure. 2011;19:162–71. doi:10.1016/j.str.2010.12.004. PMID:21300286.
   PubMed Web of Science ®Google Scholar
• Deora A, Hegde S, Lee J, Choi CH, Chang Q, Lee C, Eaton L, Tang H, Wang D, Lee D, et al. Transmembrane TNF-dependent uptake of anti-TNF antibodies. MAbs. 2017;9:680–95. doi:10.1080/19420862.2017.1304869. PMID:28323513.
   PubMed Web of Science ®Google Scholar
• Hsieh SL, Lin WW. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions. J Biomed Sci. 2017;24:39. doi:10.1186/s12929-017-0347-7. PMID:28629361.
   PubMed Web of Science ®Google Scholar
• Antoniou, E, Margonis GA, Angelou A, Pikouli A, Argiri P, Karavokyros I, Papalois A, Pikoulis E. The TNBS-induced colitis animal model: An overview. Ann Med Surg (Lond). 2016;11:9–15. doi:10.1016/j.amsu.2016.07.019. PMID:27656280.
   PubMed Web of Science ®Google Scholar
• Merkley SA, Beaulieu DB, Horst S, Duley C, Annis K, Nohl A, Schwartz DA. Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments. Inflamm Bowel Dis. 2015;21:1854–9. doi:10.1097/MIB.0000000000000456. PMID:25993689.
   PubMed Web of Science ®Google Scholar
• Durocher Y, Perret S, Kamen, A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 2002;30, E9. doi:10.1093/nar/30.2.e9. PMID:11788735.
   PubMed Web of Science ®Google Scholar
• Jin T, Guo F, Kim S, Howard A, Zhang YZ. X-ray crystal structure of TNF ligand family member TL1A at 2.1A. Biochem Biophys Res Commun. 2007;364:1–6. doi:10.1016/j.bbrc.2007.09.097. PMID:17935696.
   PubMed Web of Science ®Google Scholar